Consistent with previous studies, our result demonstrated that the plasma GFAP level was significantly higher in the PD group than in the HC group; however, there were no significant differences in GFAP levels within the different cognitive levels and subtypes in PD-MCI. The gene discussed is GFAP; the disease is Parkinson disease.